About
Senior Medical Laboratory Scientist and Lecturer with 19+
years of clinical laboratory experience and 15+ years of
teaching in Medical Laboratory Sciences, specializing in
Clinical Chemistry, Biochemistry, Enzymology, Molecular
Techniques, and Laboratory Quality Assurance.
Extensive experience in CAP accreditation, CLSI standards,
laboratory management, and undergraduate clinical
training, with active involvement in research, student
mentorship, and institutional quality frameworks. Internationally
certified ASCPi Specialist in Chemistry with multi-licensure across UAE regulatory bodies.
marwan@gmu.ac.ae | wan11mar@yahoo.com
LinkedIn: https://www.linkedin.com/in/marwan-ismail-
a6209469/
Google Scholar: https://scholar.google.com/citations?
user=GyWZ1tAAAAAJ&hl=en
ResearchGate: https://www.researchgate.net/profile/Marwan-
Ismail-3
SciProfiles: 4324069
Loop profile: 3202794
ORCID: 0000-0001-5692-1632
Research keywords
Publications
25Is Thrombocytopenia an Indicator of Malaria in Adult Patients? Assessment of Hematological Parameters in a Pilot Retrospective Study
Abstract: BACKGROUND: Malaria causes hematological alterations detectable by routine complete blood count (CBC) testing. Thrombocytopenia is the most common hematological abnormality in patients with acute malaria. Malaria is not endemic in the UAE; local transmission was eliminated, and the country is considered malaria-free. OBJECTIVE: To conduct a pilot retrospective study to evaluate malaria-associated changes in CBC parameters among adult patients with laboratory-confirmed malaria, using established reference (normal) ranges as the main comparator, with particular focus on thrombocytopenia. MATERIALS AND METHODS: This pilot retrospective review used de-identifications records from Thumbay Labs, Thumbay University Hospital (Ajman) 6 months’ worth of data. Most malaria cases reported in the UAE are imported, primarily among travelers and migrant workers from endemic countries. The study was conducted among individuals aged 18–65 years with laboratory-confirmed malaria (via microscopy or rapid diagnostic tests) who had a CBC performed on the same calendar day. Records were excluded from patients with known hematologic disorders, pregnancy, currently receiving chemotherapy or systemic steroid therapy, and incomplete CBC results. SPSS was used for statistical analysis, using descriptive statistics and one-sample tests of mean versus standard reference ranges; P < 0.05 was our threshold for statistical significance. RESULTS: In 34 adult malaria patients (pilot sample), mean ± standard deviation values were: Hemoglobin 12.67 ± 2.36 g/dL ( P = 0.180 vs. reference), hematocrit 37.58% ±6.79% ( P = 0.201), red blood cell 4.64 ± 0.79 × 10 6 /μL ( P = 0.66), mean corpuscular volume 81.13 ± 7.43 fL ( P = 0.503), mean corpuscular hemoglobin (MCH) 27.37 ± 2.82 pg ( P = 0.597), MCH concentration 33.69 ± 0.99 g/dL ( P = 0.80), red cell distribution width 14.47% ±1.79% ( P = 0.611), and white blood cell 5.96 ± 2.19 × 10 3 /μL ( P = 0.320), all largely within or near normal ranges. In contrast, there was marked thrombocytopenia: platelets 93.76 ± 55.37 × 10 3 /μL ( P < 0.00001 vs normal range), monocytosis: monocytes 12.49% ±7.06% ( P = 0.0002 vs. reference), and low/near-normal eosinophil percentages: 1.17 ± 1.90% ( P = 0.0003). CONCLUSION: This pilot study identified thrombocytopenia and monocytosis as the predominant hematological abnormalities in adult malaria patients when compared to standard reference ranges, with other CBC parameters remaining within normal limits. Thrombocytopenia may serve as a cost-effective screening marker to support clinical suspicion of malaria, though validation through larger prospective studies is required.
Uropathogen Distribution Across Successive Positive Urine Cultures Among Female Patients with Dysglycaemia
Female patients with dysglycaemia may undergo repeated urine cultures, but longitudinal microbiological data from the Gulf are limited. We retrospectively examined successive positive urine cultures from 67 female patients attending a tertiary hospital in Ajman, United Arab Emirates, between May 2016 and September 2025. Organism identity, extended-spectrum beta-lactamase (ESBL) phenotype, HbA1c and culture dates were extracted from laboratory records. Twenty-eight participants (41.8%; 95% CI 30.5–53.7) had a second recorded positive culture and ten (14.9%; 95% CI 7.9–24.9) had a third; the median interval between the first and second cultures was 161 days (IQR 74–402). Escherichia coli was the most frequent organism at each culture. At the index culture, non-ESBL E. coli accounted for 38.8% of specimens, ESBL-producing E. coli for 25.4% and Candida species for 19.4%. Recovery of the same organism or phenotype category between the first and second cultures occurred most often with E. coli (17.9% non-ESBL; 14.3% ESBL-producing). Restricting the analysis to index cultures from 2023 to 2025 did not materially change the organism distribution. Because urinary symptoms and isolate-level susceptibility results were unavailable, positive cultures could not be classified as symptomatic infection, asymptomatic bacteriuria or candiduria, and treatment appropriateness could not be assessed. Prospective studies linking symptoms, susceptibility profiles and clinical outcomes are warranted.
Physical Activity, Myokine–Adipokine Signatures and Haemoglobin Glycation Index in Adults with Type 2 Diabetes
Background: The Hemoglobin Glycation Index (HGI) reflects variability in hemoglobin glycation beyond ambient glycaemia and is a marker of metabolic heterogeneity, cardiovascular risk and treatment response in type 2 diabetes mellitus (T2DM). Whether circulating myokines and adipokines are related to HGI, or whether relationships differ across exercise modalities, is unclear. Objective: To examine associations of circulating myokines (irisin, myostatin, myonectin, IL-6, IL-15) and adipokines (leptin, adiponectin) with HGI, and whether associations differ between physically active and sedentary individuals and across exercise modalities. Methods: Cross-sectional study of 185 adults with T2DM recruited at Thumbay Hospital, Ajman, United Arab Emirates, classified as physically active (n=98) or sedentary (n=87), with active individuals sub-grouped by predominant modality: aerobic (70), resistance (11), combined (17). Measurements were obtained after an overnight fast. HGI was calculated as the residual of HbA1c regressed on fasting plasma glucose. Mann-Whitney U, Kruskal-Wallis, Spearman correlations with false discovery rate (FDR) correction and median regression adjusted for age, sex, BMI and fasting glucose were used. Results: Active participants had lower HGI than sedentary participants (median -0.44 vs 0.12; p = 0.001), with lower BMI, fasting glucose and HbA1c. HGI differed by modality (p < 0.001), most favourable in the combined-training group and least favourable in the aerobic-only group. IL-6 was inversely correlated with HGI in active participants and leptin in sedentary participants (both FDR p < 0.05). Physical activity remained an independent predictor of lower HGI after adjustment for age, sex and BMI (β = -0.65;p< 0.001), and persisted after adjustment for IL-15 and leptin. Conclusion: Precludes causal inference; if confirmed prospectively, associations may inform individualized exercise prescription and HGI-based risk stratification.Distinct myokine-adipokine signatures were associated with glycation variability beyond mean glycaemia and combined aerobic-plus-resistance training with the most favourable HGI profile. The cross-sectional design precludes causal inference; if confirmed prospectively, associations may inform individualized exercise prescription and HGI-based risk stratification.
Laboratory-Based Retrospective Study on ANA Profile Results in Ajman: A Decade of Autoantibody Distribution by Age and Gender
Background Antinuclear antibodies (ANA) are vital in diagnosing and monitoring autoimmune diseases, with prevalence affected by demographics and environment. Aim This study analyzed ANA testing trends over a decade in Ajman, UAE, focusing on prevalence, antibody types, and demographics, filling a gap in Middle Eastern longitudinal data. Methods A retrospective, cross-sectional examination of Thumbay Labs ANA profile data from 2015 to 2025 was performed. HEp-2 cell–based indirect immunofluorescence assays were run first, followed by extractable nuclear antigen testing. In addition to age and gender, autoantibody patterns were collected. While descriptive statistics summarized prevalence, chi-square tests examined associations. Logistic regression models estimated independent ANA-positive predictor ORs and 95% CIs. Results Among 2,482 individuals tested (67.6% female), 30.7% demonstrated positivity for at least one ANA-related antibody. Anti-Ro52 (7.9%), anti-SSA/Ro (7.2%), and anti-RNP/Sm (4.3%) were the most frequently detected autoantibodies. Females exhibited significantly higher ANA positivity than males (33.1% vs. 23.1%; p < 0.001). Gender remained an independent predictor in multivariable analysis (OR = 1.42; 95% CI: 1.18–1.72), with females also showing increased odds of anti-Ro52, anti-SSA/Ro, anti-SSB/La, and anti-histone reactivity. Although age demonstrated variability in univariate analyses, it did not independently predict ANA positivity. Conclusions Our study results align with international trends and provide the first decade-long summary of ANA testing patterns in the UAE. The data establish a baseline for autoimmune disease surveillance and highlight the need for clinical–laboratory coordination and prospective studies to understand ANA reactivity in this location further.
Repurposing the Antiparasitic Agent Praziquantel for Breast Neoplasm Therapy: A Narrative Review of the Mechanistic Rationale, Current Evidence and Translational Barriers
Background: Drug repurposing has become an established route into oncology because agents with a mature safety, pharmacokinetic and manufacturing record can be advanced faster and at lower cost than new chemical entities. Praziquantel, the mainstay of antischistosomal therapy for more than four decades, has been proposed as one such candidate. Aim: This narrative review examines the case for repurposing praziquantel in breast neoplasia and does so critically rather than promotionally. Results: Three strands of mechanistic rationale are identified: Praziquantel's target in the parasite is a TRPM channel, raising the untested hypothesis that it might also target the related human TRPM channels linked to breast tumour proliferation, migration and chemoresistance; the R-enantiomer is a partial agonist at the human 5-HT2B receptor, a node in a serotonergic pathway with documented roles in mammary tumour biology; and praziquantel has been proposed to lower the apoptotic threshold of carcinoma cells through down-regulation of the X-linked inhibitor of apoptosis protein which could improve the effects of cytotoxic chemotherapy. Against this rationale, the experimental evidence is limited. No study designed to evaluate praziquantel in a breast cancer model was identified. The syntheses that studied the praziquantel chemosensitising effect in combination with paclitaxel did not show direct antineoplastic activity as monotherapy; a single recent paper reported a monotherapy effect of praziquantel on hepatoma lines, but this has not been tested in breast cancer. A substantial exposure gap separates the concentrations at which activity is reported in vitro from those achievable clinically, given a systemic bioavailability below 20 per cent, a plasma half-life of one to three hours and approximately 80 per cent albumin binding. The favourable tolerability record derives from single-dose mass administration rather than chronic dosing alongside cytotoxic therapy. Conclusion: We conclude that praziquantel is at present a hypothesis rather than a candidate in breast oncology, and we set out the specific studies that would be required to change that assessment.
Virulence Gene Profile and Antimicrobial Susceptibility of Staphylococcus aureus Clinical Isolates from the United Arab Emirates
Staphylococcus aureus causes infections ranging from skin and soft tissue infections to life-threatening systemic disease. The convergence of virulence determinants with antimicrobial resistance, particularly in methicillin-resistant S. aureus (MRSA), complicates management. In the United Arab Emirates (UAE), S. aureus is a major contributor to community- and hospital-acquired infections, and regional surveillance from the Gulf Cooperation Council has documented a shift toward community-associated MRSA lineages. Despite this clinical burden, granular molecular epidemiological data from the UAE remain scarce. Fifty consecutive S. aureus clinical isolates were obtained from Thumbay Laboratories, Ajman, UAE (October 2022–August 2023). Identification and antimicrobial susceptibility testing against 23 agents were performed on the MicroScan WalkAway system. Five virulence genes, namely mecA, Panton-Valentine leukocidin (PVL; lukF-S), exfoliative toxins A (eta) and B (etb), and toxic shock syndrome toxin (tst), were detected by conventional PCR. PVL was the most prevalent virulence gene (48%, 24/50), detected exclusively in pus isolates. mecA carriage, confirming MRSA, was identified in 44% (22/50), with PVL–mecA co-occurrence in 22% (11/50). eta was present in 6% (3/50), and etb and tst each in 2% (1/50). Resistance was highest for ampicillin and penicillin (86% each), while full susceptibility (100%) was retained for vancomycin, linezolid, daptomycin, teicoplanin, rifampin, Synercid, and trimethoprim. mecA carriage was significantly associated with resistance to amoxicillin, clavulanate, ampicillin, imipenem, penicillin, oxacillin, azithromycin, erythromycin, and ciprofloxacin (p < 0.05). This study provides the first integrated molecular characterization of key S. aureus virulence determinants, along with a comprehensive antimicrobial susceptibility profile in the UAE. The high PVL prevalence and substantial MRSA burden highlight the need for structured regional surveillance and antimicrobial stewardship, while retained susceptibility to last-resort agents offer actionable guidance for empirical therapy.
Bridging the digital health gap: telemedicine readiness, confidence, and training needs among health profession students in the United Arab Emirates
Telemedicine has expanded since the COVID-19 pandemic, underscoring the need to equip future healthcare workers with digital health competencies. This cross-sectional study at Gulf Medical University, Ajman, UAE, evaluated telemedicine readiness among 1000 health profession students across nine academic programs (response rate 76.9%). Only 14.9% reported familiarity with telemedicine and 19.8% felt confident in its use, while 42.5% reported no familiarity and 33.5% lacked confidence. Although 74% engaged in self-directed learning, only 25% had received formal telemedicine education. Formally trained students were significantly more likely to pursue self-training (p=0.0125) and demonstrated higher confidence (p<0.001). In multivariable ordinal regression, self-directed training [adjusted odds ratio (aOR) 5.93, 95% confidence interval (CI) 3.10-11.33] and formal education (aOR 3.26, 95% CI 1.78-5.97) independently predicted higher familiarity and confidence, whereas program affiliation did not. Clinical-year students reported lower confidence than pre-clinical peers (aOR 0.57, 95% CI 0.33-0.97). Formal education was the sole independent predictor of believing telemedicine would improve clinical skills (aOR 2.64, 95% CI 1.30-5.36). Most students (70.2%) supported curriculum integration. Readiness gaps are driven by training exposure rather than program affiliation, highlighting the need for a structured, longitudinal, university-wide telemedicine curriculum.
Peer Review Report For: Laboratory-Based Retrospective Study on ANA Profile Results in Ajman: A Decade of Autoantibody Distribution by Age and Gender [version 1; peer review: 1 approved with reservations]
Background Antinuclear antibodies (ANA) are vital in diagnosing and monitoring autoimmune diseases, with prevalence affected by demographics and environment. Aim This study analyzed ANA testing trends over a decade in Ajman, UAE, focusing on prevalence, antibody types, and demographics, filling a gap in Middle Eastern longitudinal data. Methods A retrospective, cross-sectional examination of Thumbay Labs ANA profile data from 2015 to 2025 was performed. HEp-2 cell–based indirect immunofluorescence assays were run first, followed by extractable nuclear antigen testing. In addition to age and gender, autoantibody patterns were collected. While descriptive statistics summarized prevalence, chi-square tests examined associations. Logistic regression models estimated independent ANA-positive predictor ORs and 95% CIs. Results Among 2,482 individuals tested (67.6% female), 30.7% demonstrated positivity for at least one ANA-related antibody. Anti-Ro52 (7.9%), anti-SSA/Ro (7.2%), and anti-RNP/Sm (4.3%) were the most frequently detected autoantibodies. Females exhibited significantly higher ANA positivity than males (33.1% vs. 23.1%; p < 0.001). Gender remained an independent predictor in multivariable analysis (OR = 1.42; 95% CI: 1.18–1.72), with females also showing increased odds of anti-Ro52, anti-SSA/Ro, anti-SSB/La, and anti-histone reactivity. Although age demonstrated variability in univariate analyses, it did not independently predict ANA positivity. Conclusions Our study results align with international trends and provide the first decade-long summary of ANA testing patterns in the UAE. The data establish a baseline for autoimmune disease surveillance and highlight the need for clinical–laboratory coordination and prospective studies to understand ANA reactivity in this location further.
Correlation of circulating diabetes markers with elevated serum antithyroglobulin antibodies in type 2 diabetes patients
A total of 250 males and females were recruited to participate in this cross-sectional and case-control study that aimed at measuring several biomarkers [fasting blood glucose (FBG), glycated hemoglobin (HbA1c), thyroid hormonal profile, and antithyroglobulin antibody (ATG)] in diabetic and non-diabetic patients and comparing circulating markers of diabetes mellitus with elevated serum ATG levels in type II diabetes patients who used various analyzers. The assays were performed on Roche COBAS C311, COBAS e 411/601, and Beckman Coulter (DXC 700 AU) analyzers. The mean and standard deviation were calculated, and the independent t-test and one-way analysis of variance were used for comparison. Linear regression was conducted to assess correlations. A p-value of <0.05 was considered statistically significant. This study included 125 diabetic patients compared with 125 healthy males and females, with ages ranging from 20 to 81 years and a duration of diabetes mellitus between 4 and 15 years. The results demonstrated a significant difference in FBG, HbA1c, thyroid-stimulating hormone (TSH), free triiodothyronine (FT3), free thyroxine (FT4), and ATG levels between the diabetic patients and the healthy individuals, compared to age, gender, and duration of the disease. A moderate positive correlation was observed between FBG and HbA1c, as well as between FT3 and FT4; a negative correlation was found between FBG and HbA1c levels and TSH levels. A significant positive correlation between ATG and serum TSH levels observed in patients with type 2 diabetes mellitus indicated a strong relationship between thyroid dysfunction and diabetes, compared to the age and duration of the disease.
Exercise, myonectin response, and insulin resistance among overweight, obese and healthy individuals: a systematic review and narrative synthesis
Myonectin, a novel muscle-derived peptide or myokine, has been implicated in glucose and lipid homeostasis through its autocrine, paracrine, and endocrine functions. This review aimed to explore the impact of structured exercise interventions on myonectin levels and insulin resistance indicators in healthy individuals and those living with overweight or obesity. We performed a search of PubMed, Science Direct, CINAHL, TRIP Database, Cochrane Library, and Google Scholar for studies published until July 2022. The key terms used were "prediabetes", "overweight", "obesity", "myonectin", "Complement 1q / tumor necrosis factor-related protein 5 (CTRP5 or C1qTNF5)", "erythroferrone", and "exercise". Eight studies investigated the effects of exercise on myonectin levels and insulin resistance, measured through the Homeostatic Model Assessment for Insulin Resistance (HOMA-IR), in individuals who were overweight or obese, while six studies focused on those without these conditions. After data extraction, narrative qualitative synthesis and risk of bias analysis were performed. Findings indicate that structured aerobic or combined aerobic and resistance training at moderate intensity over 8-12 weeks led to significant increases in myonectin levels and reductions in insulin resistance, particularly among women who were overweight or obese. However, data was limited by heterogeneous age and gender groups' metabolic profiles and variability in exercise protocols. Myonectin response to exercise in healthy adults remains unclear due to baseline metabolic variability, though some improvements in the glucose-insulin axis were noted. This review suggests that myonectin may serve as a valuable biomarker to assess the impact of exercise on insulin sensitivity in individuals at risk of diabetes with overweight or obesity.
The impact of artificial intelligence on the prescribing, selection, resistance, and stewardship of antimicrobials: a scoping review
BACKGROUND: Antimicrobial selection, prescribing, and resistance are global health issues resulting from the overuse and misuse of antimicrobials in the healthcare and agricultural sectors. It raises healthcare costs, prolongs diseases, and escalates mortality. OBJECTIVE: The current study objective was to specifically explore how Artificial Intelligence and Machine Learning affect the selection of antimicrobials, address antimicrobial resistance, and strengthen antimicrobial stewardship programs through a structured scoping review. The aim was to clarify what direct impacts AI/ML have in these areas and how they contribute to improvements and challenges in practice. METHOD: A literature search was conducted in PubMed, Cochrane Library, Ovid Embase, Scopus, and CINAHL. A detailed search approach was developed to guarantee that all relevant studies were included. The entire electronic search strategy included terms such as “Artificial intelligence-AI,” “digital health,” “selection/prescribing of antimicrobials, “antimicrobial stewardship-AMS, “antimicrobial resistance-AMR, “Machine Learning-ML”, and “telemedicine,”. RESULTS: A critical appraisal of sources of evidence from the included studies was conducted using the Newcastle-Ottawa Quality Assessment Form. For this review, 70 sources related to artificial intelligence’s impact on antimicrobial selection/prescribing, resistance, and stewardship were initially screened. Of these, 33 were assessed for eligibility, resulting in 16 studies included in the review. Seventeen were excluded for lack of direct information relevant to AI’s effect on antimicrobial prescribing, resistance, and stewardship. This scoping review summarizes how artificial intelligence improves the accuracy of therapy selection, helps reduce inappropriate prescriptions by predicting necessity, and aids clinical decision-making (CDSS). It also details specific barriers, such as integration challenges, and facilitators like improved workflow, to incorporating artificial intelligence technologies in real-world clinical settings. CONCLUSION: The reviewed studies showed that Artificial Intelligence and Machine Learning improve selection, prescribing, antimicrobial resistance, and antimicrobial stewardship. The use of artificial intelligence and Machine Learning models in selection, prescribing, antimicrobial resistance, and antimicrobial stewardship has a profound impact on clinical outcomes. The utilization of Artificial Intelligence and Machine Learning enhances prescription accuracy in AMS programs. The use of Machine Learning optimizes antimicrobial selection and predicts resistance. Future research should examine the implementation of Artificial Intelligence, Machine Learning, and AI-CDSS over a more extended period to understand its long-term effects on professional practices and organizational structures.
Evaluation of Ki67 Biomarker as a Prognostic Marker in Breast Invasive Ductal Carcinoma in Khartoum State in Sudan
Introduction: Worldwide, breast cancer is the most prevalent cancer among women to be diagnosed, and it is the primary cause of cancer-related mortality, coming in second only to lung cancer. High levels of Ki67, a nuclear marker of cell proliferation, in breast cancer are linked to worse outcomes. Methods and materials: This retrospective cross-sectional laboratory investigation aimed to examine Ki67 expression as a prognostic predictor in invasive ductal carcinoma (IDC) utilizing manual tissue microarrays (MTMAs) technology. The study was done from June 2018 to July 2019 at the Elrahman Health Centre in Khartoum, Sudan, using thirty-five paraffin block samples collected from patients previously diagnosed with invasive ductal carcinoma (IDC). The study population ranged in age from 31 to 71 years. Results: The study found that 94.3% (n=33/35) of the tissues were positive for the Ki67 antigen, while 5.7% (n=2/35) were negative. Age and score correlation is (P=0.047), and a favorable prognosis could be the cause of the two unfavorable results. Conclusion: This study highlights the importance of the Ki67 biomarker as a prognostic indicator in invasive ductal carcinoma (IDC) of the breast. High levels of Ki67 expression (94.3%) were associated with more aggressive tumors and poorer prognostic outcomes. However, there was no significant correlation between Ki67 scores and patient age, indicating age does not influence the prognostic value of Ki67 in this cohort.
Neutrophil-lymphocyte ratio as a biomarker for urinary tract infection in female patients at Thumbay University Hospital, Ajman
Short urethras make urinary tract infections (UTIs) common in women. Therefore, bacteria can enter the bladder more easily. This research aimed to determine if the neutrophil-to-lymphocyte ratio (NLR) can be used as a biomarker in UTI patients and compare C-reactive protein (CRP) and NLR to identify which is more effective in diagnosing UTI patients. This study examined urine culture, NLR, and CRP values in blood from 101 Thumbay University Hospital patients with UTI. Control group NLR and CRP values of 100 participants were also examined. NLR mean for UTI patients was 6.9881. The NLR mean for UTI-free participants was 3.0839. Comparison of NLR values between UTI patients and non-UTI patients showed significant results (P=<0.001). Thus, patients with UTI had significantly higher NLR results than those without UTI, indicating a strong correlation between UTI and higher NLR values. Our results showed that UTI patients had higher NLR and CRP values than healthy controls. In patients with UTI, clinical assessment of symptoms and complaints should be done first, followed by NLR and CRP as inflammatory markers.
Correlation of Erythroferrone and Hepcidin Hormones with Iron Status Levels in Patients with Iron Deficiency
INTRODUCTION: Iron-deficiency anemia (IDA) can be grouped under low hepcidin and high erythroferrone (ERFE) anemia. There is a negative correlation between ERFE and hepcidin, irrespective of the type of anemia. ERFE is a mediator of the response to erythropoietic stress, suppressing hepcidin to promote the mobilization of stored iron and the absorption of dietary iron. OBJECTIVE: The objective was to determine the effect of ERFE hormone on hepcidin level as iron metabolism regulator in patients with iron deficiency (ID). METHODS: The study included 50 female patients with ID who were investigated for complete blood count, serum levels of ferritin, and serum levels of iron using automated hematology, immunology, and chemistry analyzer. ERFE and hepcidin were measured by a specific enzyme-linked immunosorbent assay kit. RESULTS: The serum ERFE levels were higher than normal in all cases and were negatively correlated with serum hepcidin ( r = −0.023). In IDA, serum ERFE concentration had a nonsignificant negative correlation with hemoglobin (Hb) concentration. Serum hepcidin concentration had a nonsignificant negative correlation with Hb concentration. Serum ERFE had a nonsignificant negative correlation with Hb% in severe IDA ( r = −0.679; P = 0.094) and mild IDA ( r = −0.068; P = 0.789). ERFE had a nonsignificant positive correlation with Hb% in moderate IDA (r = 0.069; P = 0.793). Serum hepcidin had a nonsignificant positive correlation with Hb% in severe IDA (r = 0.036; P = 0.939). Serum hepcidin had a nonsignificant negative correlation with Hb% in mild IDA ( r = −0.079; P = 0.764) and moderate IDA ( r = −0.179; P = 0.491). CONCLUSIONS: The potential of ERFE and hepcidin in diagnosing and categorizing ID disorders is promising. Understanding the mechanism of ERFE/hepcidin interaction will help in developing ERFE-/hepcidin-targeted therapies.
Evaluation of Gamma-Glutamine Transferase (γ-GT) as a Marker of Alcohol Abuse.
Introduction: Biological markers for alcohol consumption are used in clinical settings to detect and monitor alcohol consumption due to variability in verbal reporting. Alcohol consumption increases serum GGT, a widely used laboratory parameter, with gamma-glutamyl transferase sensitivity being higher than other commonly used markers, as it is known to induce a rise in serum GGT. Aim: This study aimed to investigate the role of gamma-glutamyl transferase (GGT) activity in heavy and moderate alcoholic male drinkers and controls, categorized by age group. Materials and methods: In this cross-sectional study, we analyzed GGT levels in 100 participants, divided into two groups based on alcohol consumption. The first group consumed alcohol for over five years in different amounts (heavy < 280-gram ethanol per week, moderate >280-gram ethanol per week), while the second group consisted of 50 healthy non-alcoholics as a control. Results: Subjects who consumed alcohol had blood GGT levels that were more than three times higher than those of non-drinking subjects (mean 78.06±11.01 U/L), demonstrating a substantial significance with p<0.001 and student t=4.761. the mean serum GGT levels in heavy drinkers was 125.89±109.96 U/L, higher than the mean of moderate drinkers (51.16±29.82) and abstainers (25.12±10.61 U/L), with a strong statistical significance at p<0.001 and F=27. 318. Conclusion: The serum GGT levels were significantly increased in subjects who had alcohol consumption to more than 3 folds when compared with non-alcoholic controls. Hence measurement of GGT in serum appears to be a sensitive index in the diagnosis of alcoholics.
The Association of Prolactin and CRP Biomarkers with the Severity of COVID-19 in Thumpay Hospital, Ajman, UAE
Background: This study aimed to estimate the levels of C-reactive protein (CRP) and prolactin (PRL) in SARS-CoV2 infection and their association with the severity of COVID-19 among patients in Ajman, UAE. Methods and Results:This cross-sectional study was conducted in Thumbay Hospital from 2020 to 2021.The study included 71 patients (55 males and 16 females) with positive SARS-CoV-2 test results.Nasal swab specimens were collected for the COVID-19 test on the day of admission or after one day of admission.COVID-19 diagnoses and severity levels were determined according to the New Coronavirus Pneumonia Prevention and Control Program (7th edition) published by the National Health Commission of China (2020).Serum samples were collected from the patients upon admission.The PRL level was determined using the immune chemiluminescent method by the DXI 800 Beckman Coulter analyzer.The CRP level was determined using the immunoturbidimetric method by the DXC 700 AU chemistry analyzer.Among 71 COVID-19 patients, the great majority were men 55(77.5%),38(53.5%)being of Indian nationality.In this study, most participants (50.7%) had no history of chronic illnesses.In terms of COVID-19 severity, 24(33.8%) of patients had mild cases, 27(38.0%)had moderate cases, and 20(28.2%)had severe cases.Twenty (28.2%) patients were transferred to the ICU, and 19(26.8%)were intubated.The patients' average age was 47.58±13.63,CRP level -74.30±71.46mg/L, and PRL level -205.1946±168.52ng/mL.The mean CRP level was highest in severe cases, compared to mild and moderate cases, with a statistically significant difference between mild and severe groups (P=0.000) and mild and moderate groups (P=0.004).The mean PRL level was highest in severe cases compared to mild and moderate cases; however, the differences between the groups were not significant.CRP and PRL levels were greater in the ICU patients than non-ICU patients, with statistically significant differences only for CRP.We found a moderate positive correlation between CRP level and age (r=0.458,P=0.000); a weak positive correlation between PRL level and age was not statistically significant (r=0.201,P=0.093).A moderate positive correlation between CRP level and PRL level (r=0.461,P=0.03) was statistically significant. Conclusion:The current study implies that serum CRP levels might be an important indication of COVID-19 development and severity.A more extensive study with a larger sample size is needed to validate the significance of PRL in disease severity.
Association of Serum Procalcitonin Level with Severity of COVID-19 among Patients in Ajman, United Arab Emirates
The aim of the current study was to assess the association between the mean level of procalcitonin (PCT), demographic characteristics, and the symptoms, duration, and severity of COVID-19. Methods and Results: This cross-sectional study included patients with a confirmed COVID-19 infection who visited the Thumbay Hospital in Ajman (UAE) between March and June 2022. A total of 231 COVID-19-positive patient records (170[73.6%] males and 61[26.4%] females) were included in the study. PCT levels were measured upon admission using the Beckman Coulter – UniCel DxI 800 Access Immunoassay System. The mean patients’ age was 47.44±13.460 years, and the length of stay in the hospital was 11.21±8.145 days. The PCT mean level was 0.545±1.739 ng/ml with minimum and maximum values of 0.010 ng/ml and 16.667 ng/ml, respectively. In terms of COVID-19 severity, patients were categorized into mild (121[52.4%]), moderate (59[25.5%]), and severe 51(22.1%]). We found no association between age categories and COVID-19 severity. There was a statistically significant difference in the mean PCT level among the severity groups. The mean PCT level increased with increasing severity of COVID-19: 0.0569±0.0324, 0.1736±0.0594, and 2.134±3.254 ng/ml for mild, moderate, and severe COVID-19, respectively (P=0.0000) There was a statistically significant, moderate positive correlation between PCT level and disease severity (r=0.433, P=0.001). The linear regression results revealed that PCT level is a significant factor in COVID-19 severity. Conclusion: The current study demonstrates that the serum PCT level may be a marker of disease severity in patients infected with SARS-CoV-2.
Correlation of Haematological Parameters and Glycated Hemoglobin to Vitamin D level in Type II Diabetes Mellitus Patients Attend Thumbay hospital, Ajman, UAE
Objective: This study is designed to evaluate the relationship between the hematological parameter, vitamin D level along with HbA1C level in type 2 diabetic patients. Material and Methods: The current study is a cross-sectional study that included 150 patients with type 2 diabetes mellitus aged 20 to 79 years. Patients were given a questionnaire that included demographic information, family history, duration of diabetes, and the presence of associated complications. During data analysis, the Mann-Whitney U-test, correlation, and descriptive statistics were used. P-values less than 0.05 were considered statistically significant. Results: CBC parameters show low RBC, HCT, and Hgb count and increase in RDW value among T2DM individuals. WBCs and monocytes count were insignificant statistically (P= 0.925, P= 0.084), but showed a weak positive correlation which could be used as an inflammation marker. In addition, most of the T2DM were having vitamin D deficiency (<20 ng/mL) around 72.7% and occurs more in patients suffering from the diabetic disease for more than 5 years. Conclusions: This study highlights that T2DM patients could have one or more diabetes related complications at the time of diagnosis. Anemia was common among T2DM patients, especially patients with poorly controlled HbA1c because of diabetic nephropathy that affects the production of EPO. The study results demonstrated that vitamin D deficiency is common among T2DM patients. Therefore, it is recommended to screen and treat vitamin D deficiency for individuals whose diabetes risk is increased.
The Association of C-Reactive Protein and Ferritin Levels with the Severity of COVID-19 in Ajman, UAE
Background: SARS-Cov-2, a new strain of coronavirus first identified in Wuhan city, China, has spread worldwide, causing severe illnesses and a high mortality rate. Many studies have shown the association of elevated levels of pro-inflammatory markers, such as ferritin and C-reactive protein (CRP), with the severe course of coronavirus disease The aim of this research was to investigate the association between CRP and ferritin levels, and the severity of COVID-19. Methods and Results: This cross-sectional study was performed in Thumbay Hospital, Ajman, United Arab Emirates, from January 2021 to October 2021. A total of 100 COVID-19 positive patients were included in this study. Serum CRP and ferritin were measured by immunoturbidimetric assay. We found statistically significant differences between ferritin levels and disease severity (P=0.005), age category (P=0.030), and the clinical wards (P=0.016). Statistically significant differences were found between the ferritin levels in mild to moderate cases (P=0.023) and mild to severe cases (P=0.007). There were significant differences in CRP in mild to moderate cases (P=0.012), and in mild to severe cases (P=0.000). Thus, the results obtained showed that CRP and ferritin levels are considerably greater in severe cases than in mild and moderate cases of COVID-19. The findings of the current study indicate that CRP and serum ferritin levels might be considered as an essential indication of the progression and severity of COVID-19.
Serum Procalcitonin Level and Comorbidity in Covid-19 Patients in UAE
Background: Most COVID-19 patients experience a mild form of the disease, but there is a certain percentage of patients who progress to a very severe disease state that requires intensive care and invasive ventilation. In order to ensure better patient management and improved outcomes, early identification of patients who may be at a higher risk of severe infection can play an important role. The aim of this study was to assess the association between the mean procalcitonin (PCT) level and comorbidity in hospitalized patients with COVID-19. Methods and Results: A total of 231 COVID-19-positive patients aged between 20 and 82 years (170[73.6 %] males and 61[26.4%] females) were included in this study. Serum PCT was accessed by procalcitonin assay using the Beckman Coulter UniCel DxI 800 instrument. Eighty-seven (37.7%) patients had no chronic disease, while 144(62.3%) had comorbidities: hypertension (37[16.0%]), diabetes mellitus (44[19.0%]), a combination of diabetes mellitus with hypertension (32[13.9%]), asthma (6[2.6%]), hyperlipidemia (4[1.7%]), renal disease (1[0.4%]), and COPD (1[0.4%]). COVID-19 patients with diabetes in combination with hypertension had a statistically greater PCT level than COVID-19 patients without comorbidities (P=0.0273). However, there were no statistically significant differences in the mean PCT level between different age categories (P=0 .7390). The serum PCT measurement could evaluate the prognosis of the disease in some COVID-19 patients.
Estimation of Serum Creatinine, Aspartate Aminotransferase, Alanine Transaminase, and Hemoglobin A1c% Levels among Diabetic Patients using Metformin/Dipeptide Peptidase-4 Inhibitor Combination and Insulin – A Cross-Sectional Study
BACKGROUND: Diabetes is a leading cause of morbidity and mortality worldwide, imposing a considerable burden on health systems and societies as it affects both individuals and their families and has a large impact on the economic and social development of a country. Nowadays, to treat diabetes, patients are taking drugs such as metformin in combination with dipeptide peptidase-4 (DPP-4) inhibitors and insulin for their treatment. There are many physiological and pathological changes while taking drugs for treating diabetes.AIM: Through this research, we can have an idea about the health of the patient and help to detect the level in which different drugs are affecting the patient’s kidney and liver. METHODS: A cross-sectional study was done on diabetes type 1 and type 2 diabetic patients who are undergoing treatment with insulin and DPP-4 inhibitors/metformin combination drugs. The study continued for 3 months including preparation, practice, and data analysis. RESULTS: In this study, our results show there is no significant change in all biochemical parameters: aspartate aminotransferase (AST), alanine transaminase, creatinine, and hemoglobin A1c (HbA1c) between diabetic patients treated with insulin and metformin/DPP-4 combination. CONCLUSION: Metformin/DPP-4 combination gives a better glycemic control than other medications, whereas the levels of AST, creatinine, and HbA1c are unaffected using either insulin or metformin/DPP-4 inhibitors combination.
Diffractive Phase Interferometry (DPI), CRP and COVID-19 RT-PCR Tests in COVID-19 Patients with Different Ages in AJMAN, UAE: A Comparative Study
Background: Fast and accurate diagnosis plays an important role in controlling and further preventing COVID-19. This study was conducted in the Thumbay laboratory of Gulf Medical University (Ajman, UAE) to assess the correlations between DPI (Diffractive Phase Interferometry), COVID-19 RT-PCR, and CRP tests in COVID-19 patients of different ages and to compare the effectiveness of each parameter. Methods and Results: A cross-sectional analytic study was conducted among 150 patients diagnosed with COVID-19 who were admitted to the Thumbay University Hospital. Their general data was collected from the LDM system, and from among the suspected patients who came to do the RT-PCR test, 230 were selected as volunteers to participate in this study, and further laboratory tests like CRP level and DPI test were done for them. The nasal swab was collected for a PCR test. Out of 230 nasal swab samples, 150 were positive and 80 were negative for SARS-CoV-2 RNA by real-time RT-PCR assay. Among the 150 positive RT-PCR, 90 false negative DPI tests were from a sample with a high real-time RT-PCR. While 60 true positive DPI tests were positive real-time RT-PCR for swab specimens. Among the 80 negative RT-PCR, 79 were true negative and 1 was a false positive. The predictive positive value of the DPI test was 40% and the predictive negative value of the test was 98%. DPI has at least one tie between the positive actual state group and the negative actual state group. The results show weak and moderate positive correlations between CRP and the age groups. Conclusion: The combined detection of the three indicators (RT-PCR, DPI, and CRP) are positively related to COVID-19 infection; therefore, these indicators will enable effective intervention measures to be implemented in time and the rates of severe illness and mortality to be reduced.
Circulating Markers of Adipocytokines levels and BMI in Insulin Resistance Females with Type2 diabetes
Background and aim: Obesity is one of the main factors that lead to development of type 2 diabetes mellitus (T2DM), with the prevalence of both increasing worldwide. Obesity is a modifiable risk factor related with many complications and comorbidities. This study aims to evaluate the level of Resistine, Fasting Blood Glucose and Adiponectin compare with the BMI in Insulin Resistance females with Type2 diabetes. Methods: A descriptive cross-sectional - case-control study, the target population is a total 205 Sudanese females were recruited to participate in this study, aged 35-64 years, venous blood samples were collected. Plasma levels of blood glucose were measured using the particle-enhanced immunoturbidimetric assay method Cobas C-311®.While Adiponectin and Resistine estimated by ELISA Kits. Anthropometric measurements, including height and weight, were taken using standard protocols. BMI was calculated as weight (in kilograms) divided by height (in meters squared). Results: Observed from these results significant difference between the means of fasting blood glucose (FBG), adiponectin, esistine and BMI compared with different group classified according to WHO body mass index (BMI) Classification. FBG in underweight (125 ± 15.9), FBG in healthy weight (127 ± 16.7),FBG in overweight (153 ± 19.2) , FBG in obesity (169 ± 20.7), FBG in sever obesity(189 ± 23.7),, P = 0.037, adiponectin in underweight (12.3 ± 1.1),adiponectin in healthy weight (11.2 ± 1.9), adiponectin in overweight (9.7 ± 1.6), adiponectin in obesity (6.1 ±1.5),adiponectin in sever obesity (6.8 ± 1.9), P = 0.043, resistine in underweight (11.6 ± 1.9) , resistine in healthy weight (12.8 ± 1.1), resistine in overweight (14.2 ± 2.7) resistine in obesity (18.2 ± 2.9), resistine in sever obesity (19.1 ± 3.4) , P = 0.021, BMI in underweight(16.5 ± 1.9), BMI in healthy weight (18.3 ± 1.7),BMI in overweight (26.1 ± 2.2),BMI in obesity (30.4 ± 3.7),BMI in sever obesity (40.1 ± 4.0), P = 0.006). In this study, the results show strong negative Correlation between the levels of serum Adiponectin and Fasting Blood Glucose. (P.value = 0.013, r = -7.9), Adiponectin and Resistine. (P.value = 0.019, r = -6.6). In the other side strong positive Correlation between the levels of serum Resistine and Fasting Blood Glucose. (P.value = 0.015, r = 6.0). Observed from this results negative Relationship between the mean of BMI compared with the history of the patient/ years. Conclusion: This study concluded that BMI effected on Adipocytokines levels and Increased risk of insulin resistance in females with Type2 diabetes by increased the level of resistine, fasting blood glucose and reduced of adiponectin in different groups classified according to WHO body mass index (BMI) Classification.
Vitamin D Deficiency among Females with Acne Vulgaris in Relation to Sun Exposure: A Cross-sectional Study
BACKGROUND: Acne vulgaris is a common chronic inflammatory disease of the skin. Vitamin D deficiency has been implicated in various skin diseases, including atopic dermatitis and psoriasis. AIM: The aim of this study was to evaluate the serum 25-hydroxy Vitamin D levels among patients with acne vulgaris. METHODS: This was a cross-sectional comparative study performed in Khartoum state at Military hospital, department of dermatology and venerology, 111 blood samples were collected from females to measure serum level of 25-hydroxy Vitamin D by immunoassay analyzer cobas-e-411-2ed generation platform of Electrochemiluminescence binding assay. RESULTS: In this study, 111 females their age 18–36 years. 57 suffering from acne vulgaris, 61.4% of them had moderate grade of acne. A significant decrease in the serum 25-hydroxy Vitamin D concentrations in acne vulgaris patients when compared to 54 non-acne group (13.3 ± 5.0 ng/mL vs. 24.2 ± 10.3 ng/mL p =0.00). Significant positive correlation between serum 25-OH Vitamin D and exposure to sunlight per day (r = 0.562, p = 0.00), while there was a significant negative correlation between 25-OH Vitamin D and grade of acne, and duration of disease per month (for grade of acne r = –0.641, p = 0.00), (for duration of disease r = –0.696, p = 0.00) among patients with acne vulgaris. CONCLUSION: The evidence from this study suggests that female with low serum 25- OH Vitamin D had increase risk to develop acne vulgaris. Further studies are needed to confirm this potential relation.
Lack of Association between Factor V Leiden G1691A, Prothrombin G20210A, MTHFC677T Mutations, and Early Recurrent Pregnancy Loss in a Group of Sudanese Women
BACKGROUND: Recurrent pregnancy loss is classically defined as the occurrence of three or more consecutive pregnancy loss. Recurrent pregnancy loss affects from 1-5% of the reproductive age couples. This diagnosis is both emotionally challenging and confusing for most couples, as the definitive diagnosis using conventional evaluations is found in fewer than half of the couples experiencing repeated loss. AIM: The purpose of this study was to define the association between Factor V Leiden G1691A, Prothrombin G20210A, MTHFC677T mutations and recurrent pregnancy loss in a group of Sudanese women. MATERIALS AND METHODS: This a retrospective analytical case control study was carried out at Omdurman Maternal Hospital, Sudan between July 2013 to July 2015. Consent was obtained from the ethical committee of the Faculty Research Board and Hospital of Omdurman Maternity Hospital (Sudan). The study included a hundred pregnant females with a history of recurrent spontaneous abortion as the (case group) and ninety-five healthy reproductive Sudanese women as the (control group). The data was collected with the help of a structured questionnaire and direct interview to collect information. Identification of point mutation in factor V Leiden G1691A, prothrombin G20210A and MTHF C677T gene by polymerase chain reaction was performed. The odds ratio and the 95% confidence interval (95%CI) were calculated for the presence of mutation case group and the control group and analyzed by SPSS program, version 17.0. RESULTS: The frequency of prothrombin G20210A, MTHFC677T, was low overall, except for the Factor V Leiden G1691A. The differences between patients and controls had no statistical significance (P- Value>0.05). CONCLUSION: Our study confirms the low prevalence of inherited thrombophilias in Sudanese populations and it is unlikely that the tested thrombophilias play a role in the pathogenesis of recurrent pregnancy loss in the Sudanse population.Therefore, we conclude that the low prevalence of Factor V Leiden, prothrombin G20210A and MTHFC677T in Sudanese women with RPL and does not play a role in the pathogenesis of recurrent pregnancy loss among our population.